ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LITS vs IXHL // RETURN ON INVESTED CAPITAL (ROIC)

Lite Strategy Inc. (NASDAQ) VS. Incannex Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: LITS 2 — IXHL 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LITS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LITS VS. IXHL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LITS IXHL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -18.90% -35.00% +16.10 LITS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.68 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 IXHL /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.9 27.0 +8.90 LITS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $29.4M $29.9M -$431.1K IXHL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LITS REV IXHL REV LITS GROSS % IXHL GROSS % LITS FCF IXHL FCF
FY 2025 $48.9M $66.6M — — -$20.8M -$12.5M
FY 2024 $65.3M $12.0K — — -$50.5M -$16.1M
FY 2023 $48.8M $139.1M — — -$52.5M -$10.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LITS // BETA —
IXHL // BETA —